论文部分内容阅读
目的探讨莫沙必利及铝镁加混悬液对胆汁反流性胃炎的疗效。方法将120例胆汁反流性胃炎随机分为A、B、C组。A组(40例)服用莫沙必利5 mg/次,3次/d;B组(40例)服用铝镁加混悬液1.5 g/次,3次/d;C组(40例)同时服用莫沙必利及铝镁加混悬液,剂量同A、B组。治疗4周后观察治疗效果。结果治疗后三组患者症状均明显减轻(P<0.05),C组症状改善更明显(P<0.05)。结论莫沙必利、铝碳酸镁联合应用是胆汁反流性胃炎的首选治疗方案。
Objective To investigate the curative effect of mosapride and aluminum magnesium mixed suspension on bile reflux gastritis. Methods 120 cases of bile reflux gastritis were randomly divided into A, B and C groups. Group A (40 cases) took mosapride 5 mg / time, 3 times / d; Group B (40 cases) took aluminum magnesium mixed suspension 1.5 g / time 3 times / d; Group C (40 cases) Mosapride and Al-Mg plus suspension at the same time, the same dose with A, B group. After 4 weeks of treatment, the effect of treatment was observed. Results After treatment, the symptoms of the three groups were significantly relieved (P <0.05), while the symptoms of the C group were improved more significantly (P <0.05). Conclusion Mosapride and magnesium aluminum carbonate are the first choice of treatment for bile reflux gastritis.